These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2663036)

  • 1. Control of mineral metabolism in CAPD patients.
    Delmez JA
    Blood Purif; 1989; 7(2-3):167-80. PubMed ID: 2663036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract]   [Full Text] [Related]  

  • 3. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.
    Delmez JA; Slatopolsky E; Martin KJ; Gearing BN; Harter HR
    Kidney Int; 1982 Jun; 21(6):862-7. PubMed ID: 6897087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R
    Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ; Gokal R
    Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
    Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minerals and bone-modulating hormones in children on continuous ambulatory peritoneal dialysis.
    Freundlich M; Zilleruelo G; Abitbol C; Hwang KH; Bourgoignie JJ; Strauss J
    Nephron; 1985; 41(3):267-72. PubMed ID: 3840576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal osteodystrophy.
    Kanis JA; Cundy TF; Hamdy NA
    Baillieres Clin Endocrinol Metab; 1988 Feb; 2(1):193-241. PubMed ID: 3044329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and phosphorus in diet therapy of uremia.
    Schoolwerth AC; Engle JE
    J Am Diet Assoc; 1975 May; 66(5):460-4. PubMed ID: 1123506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal osteodystrophy.
    Coburn JW; Henry DA
    Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients.
    Sugimoto T; Yamakado M; Matsushita K; Iwamoto T; Tagawa H
    J Int Med Res; 2002; 30(6):566-75. PubMed ID: 12526283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone.
    Chesney RW; Mehls O; Anast CS; Brown E; Hammerman MR; Portale A; Fallon MD; Mahan J; Alfrey AC
    Am J Kidney Dis; 1986 Apr; 7(4):275-84. PubMed ID: 3515907
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral metabolism in CAPD.
    Hamdy NA; Brown CB; Boletis J; Boyle G; Tindale W; Beneton MN; Charlesworth D; Kanis JA
    Contrib Nephrol; 1990; 85():100-10. PubMed ID: 2078928
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of calcium carbonate and low-dose vitamin D/1,25(OH)2D3 in reducing the risk of developing renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Jüppner H; Hoyer PF; Latta K; Winkler L; Offner G; Brodehl J
    Pediatr Nephrol; 1990 Nov; 4(6):614-7. PubMed ID: 2088463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotides in bone and mineral metabolism. II. Cyclic nucleotides and the renal regulation of mineral metabolism.
    Klahr S; Peck WA
    Adv Cyclic Nucleotide Res; 1980; 13():133-80. PubMed ID: 6251704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.